Lexicon Pharmaceuticals (LXRX) Capital Expenditures (QoQ) (2010 - 2024)
Lexicon Pharmaceuticals (LXRX) Capital Expenditures (QoQ) (2010 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Lexicon Pharmaceuticals | 979.13 Mn | 808.47 Mn | 20.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 54.40% |
| Sep 30, 2024 | 22.80% |
| Sep 30, 2023 | -40.29% |
| Jun 30, 2023 | -43.95% |
| Mar 31, 2023 | -80.10% |
| Dec 31, 2022 | 31,050.00% |
| Mar 31, 2022 | 230.43% |
| Dec 31, 2021 | -89.20% |
| Sep 30, 2021 | -77.51% |
| Jun 30, 2021 | 2,392.11% |
| Mar 31, 2021 | -29.63% |
| Dec 31, 2020 | 63.64% |
| Mar 31, 2019 | 89.19% |
| Dec 31, 2018 | 1,133.33% |
| Sep 30, 2018 | -80.00% |
| Jun 30, 2018 | -62.50% |
| Mar 31, 2018 | 900.00% |
| Dec 31, 2017 | -93.44% |
| Sep 30, 2017 | -14.08% |
| Jun 30, 2017 | -22.83% |